Li, Y. (2026). FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026. Highlights in Business, Economics and Management, 70, 94-102. https://doi.org/10.54097/n6naqe96